Related Experiment Video
Updated: Jul 16, 2026

Probiotic Studies in Neonatal Mice Using Gavage
Published on: January 27, 2019
Maternal Prebiotic Supplementation Modifies Associations Between Intrapartum Antibiotics and Infant Allergy
Summer V M Walker1,2, Thomas R Sullivan3,4, Rachelle A Pretorius1,5,6
1The Kids Research Institute Australia, The University of Western Australia, Nedlands, WA, Australia.
Insights
Maternal prebiotic supplementation during pregnancy may protect infants from allergies linked to intrapartum antibiotics. This intervention reduced risks of sensitization, food allergy, and eczema in infants exposed to antibiotics around birth.
Area of Science:
- Microbiome research
- Allergy and immunology
- Nutritional science
Background:
- Antibiotics can disrupt infant gut microbiota and increase allergy risk.
- Prebiotics promote beneficial gut bacteria, potentially counteracting antibiotic effects.
- Understanding the interplay between maternal antibiotic exposure, prebiotics, and infant allergies is crucial for prevention.
Purpose of the Study:
- To investigate if maternal antibiotic use (pre-, during, or post-birth) impacts infant allergy risk.
- To determine if maternal prebiotic supplementation modifies this risk.
- To assess allergy outcomes like sensitization, food allergy, and eczema by age one.
Main Methods:
- Mothers received prebiotics (galacto-oligosaccharides and fructo-oligosaccharides) or placebo from mid-gestation to 6 months postpartum.
- Maternal and infant antibiotic use was tracked monthly.
- Infant allergic diseases were assessed at one year of age in a cohort with a family history of allergy.
Main Results:
- Intrapartum antibiotic exposure in mothers not taking prebiotics increased infant risks of allergen sensitization, IgE-mediated food allergy, and atopic eczema.
- Maternal prebiotic supplementation negated these increased risks associated with intrapartum antibiotics.
- Antibiotic use during other intervention periods showed no significant association with infant allergy outcomes.
Conclusions:
- Maternal prebiotic intake appears to mitigate infant allergy risks associated with intrapartum antibiotic exposure.
- Prebiotic interventions during the intrapartum period may be a promising strategy for allergy prevention.
- Further research in allergy prevention trials should focus on optimizing maternal prebiotic supplementation.
Background:
Prebiotics promote growth of beneficial gut bacteria, whereas antibiotics can disrupt the microbial balance, reduce diversity, and potentially cause gut dysbiosis. This investigation aimed to determine whether antibiotic use before, during, or after birth altered the risk of infant allergic disease outcomes within a maternal prebiotic dietary supplementation trial.
Methods:
Maternal participants were allocated to consume daily prebiotics (galacto-oligosaccharides and fructo-oligosaccharides) or placebo (maltodextrin) powder from 18 to 20 weeks' gestation until 6 months postnatal. All infants had a family history of allergic disease. Maternal and infant antibiotic use was prospectively collected monthly throughout the trial intervention period, and infant allergic disease was assessed by 1 year of age.
Results:
Overall, 83.1% (472/568) mothers and 20.8% (115/554) infants received antibiotics during the trial intervention period. Prebiotic supplementation modified the association between maternal intrapartum antibiotic exposure and infant allergic disease. Among women not consuming prebiotics, maternal intrapartum antibiotics were associated with an increased risk of infant allergen sensitisation (adjusted relative risk [aRR] 3.56, 95% CI 1.65-7.69), IgE-mediated food allergy (aRR 5.67, 95% CI 2.04-15.73), and medically diagnosed atopic eczema (aRR 6.42, 95% CI 2.43-16.95); such associations were not evident in women consuming prebiotics. Maternal and infant antibiotics administered during other intervention phases were not significantly associated with any infant allergic disease outcomes.
Conclusion:
Our exploratory investigation findings indicate that maternal prebiotics supplementation reduces the risk of infant allergen sensitisation, food allergy and atopic eczema associated with intrapartum antibiotic use. Future allergy prevention trials could further optimise maternal prebiotic interventions during the intrapartum period.
More Related Videos
05:31Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
08:50A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
Published on: June 24, 2020
Related Concept Videos
Microbiota Modulation by Antibiotics
Development of Human Microbiota
Development of the Oral Microbiota
Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the small...
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Gut-Brain Axis